News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Alan L. Weiner, MD

Articles by Alan L. Weiner, MD

Correspondence regarding, "The Cost Effectiveness of Levalbuterol Versus Racemic Albuterol"

ByAlan L. Weiner, MD,Author reply by Campion Quinn, MD

January 15th 2005

Latest Updated Articles

Correspondence regarding, "The Cost Effectiveness of Levalbuterol Versus Racemic Albuterol"
Published: January 15th 2005 | Updated:

Trending on AJMC

FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis

HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.